Advances in Magnetofection & â Magnetically Guided Nucleic Acid Delievery:a Review
Home >
2013,
Vol. 1 No. 1 > Advances in Magnetofection & â Magnetically Guided Nucleic Acid Delievery:a Review
Authors
- Sandeep AroraChitkara College of Pharmacy, Chitkara University, Rajpura, Punjab-140401
- Girish GuptaOmni Active Health Technologies, Thane, Maharashtra, INDIA
- Sukhbir SinghChitkara College of Pharmacy, Chitkara University, Rajpura, Punjab-140401
- Neelam SinghChitkara College of Pharmacy, Chitkara University, Rajpura, Punjab-140401
Keywords
Magnetofection, Magnetic Nanoparticles, Nucleic Acid Therapy, Magnetic Drug Targeting
Abstract
During the last decade, nanomagnetic methods for delivering and targeting nucleic acids have been developed which are often referred to as magnetofection. Nucleic acids carry the building plans of living systems. As such, they can be exploited to make cells produce a desired protein, or to shut down the expression of endogenous genes or even to repair defective genes. Hence, nucleic acids are unique substances for research and therapy. To exploit their potential, they need to be delivered into cells which can be a challenging task in many respects. Magnetofection provides a novel tool for high throughput gene screening in vitro and can help to overcome fundamental limitations to gene therapy in vivo. Magnetofection is nucleic acid delivery to cells, supported and site-specifically guided by the attractive forces of magnetic fields acting on nucleic acid shuttles (vectors) which are associated with magnetic nanoparticles. In a magnetofection procedure, self-assembling complexes of enhancers like cationic lipids with plasmid DNA or small interfering RNA (siRNA) are associated with magnetic nanoparticles and are then concentrated at the surface of cultured cells by applying a permanent inhomogeneous magnetic field.
References
- Boussif, O. (1995) âA versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo â Polyethylenimineâ. Proceedings of the National Academy of Sciences of the United State of America, Vol 92, pp. 7297â7301Â http://dx.doi.org/10.1073/pnas.92.16.7297
- Campbell, K. Calvo, C. J. Mironov, S. Herron, T. Berenfeld, O and Jalife, J. (2012) âSpatial gradients in action potential duration created by regional magnetofection of hERG are a substrate for wavebreak and turbulent propagation in cardiomyocyte monolayersâ. J Physiol., Vol 590, 24, pp. 6363-6379Â http://dx.doi.org/10.1113/jphysiol.2012.238758
- Cotton, M. (1994) âPsoralen treatment of adenovirus particles eliminates virus replication and transcription while maintaining the endosomolytic activity of the virus capsidâ. Virology, Vol 205, pp. 254â261Â http://dx.doi.org/10.1006/viro.1994.1641
- Curiel, D.T. (1999) âStrategies to adapt adenoviral vectors for targeted deliveryâ. Annals of New York Academy of Sciences, Vol 886, pp.158â171 http://dx.doi.org/10.1111/j.1749-6632.1999.tb09409.x
- Fasbender, A. (1998) âIncorporation of adenovirus in calcium phosphate precipitates enhances gene transfer to airway epithelia in vitro and in vivoâ. J Clin Invest, Vol 102, pp. 184â193. http://dx.doi.org/10.1172/JCI2732
- Finsinger, D. (2000) âProtective copolymers for nonviral gene vectors: synthesis, vector characterization and application in gene deliveryâ. Gene Therapy, Vol 7, pp.1183â1192. http://dx.doi.org/10.1038/sj.gt.3301227
- Fouriki, A. Farrow, N. Clements, M.A. and Dobson, J. (2010) âEvaluation of the magnetic field requirements for nanomagnetic gene transfectionâ. Nano Reviews, Vol 1, 10, pp. 1-5
- Hiemenz, P.C. (1986) âPrinciples of Colloid and Surface Chemistryâ (2nd ed.) Marcel Dekker: NewYork, pp. 508-528
- Hughes, C. Galea-Lauri, J. Farzaneh, F. and Darling, D. (2001) âStreptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectorsâ. Mol Therapy, Vol 3, pp. 623â630. http://dx.doi.org/10.1006/mthe.2001.0268
- Isner, J.M. (1996) âArterial gene transfer for therapeutic angiogenesis in patients with peripheral artery diseaseâ. Human Gene Therapy, Vol 20, pp. 959â988 http://dx.doi.org/10.1089/hum.1996.7.8-959
- Kanof, M.E. Smith, P.D. and Zola, H. (1999) âPreparation of human mononuclear cell populations and subpopulations, In: Coligan JEâ. Current Protocols in Immunology. John Wiley: New York, pp. 7
- Kasahara, N. Dozy, A.M. and Kan, Y.W. (1994) âTissue-specific targeting of retroviral vectors through ligand-receptor interactionsâ. Science, Vol 266, 5189, pp. 1373â1376 http://dx.doi.org/10.1126/science.7973726
- Kru¨ger, A. Schirrmacher, V. and Von, H.P. (1994) âScattered micrometastases visualized at the single-cell level: detection and re-isolation of lacZ-labeled metastasized lymphoma cellsâ. International J Cancer, Vol 58, pp. 275â284 http://dx.doi.org/10.1002/ijc.2910580222
- Leon, R.P. (1998) âAdenoviral-mediated gene transfer in lymphocytesâ. Proceedings of the National Academy of Sciences of the United State of America, Vol 95, pp. 13159â http://dx.doi.org/10.1073/pnas.95.22.13159
- Leventis, R. and Silvius, J.R. (1990) âInteractions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphilesâ. Biochimica et biophysica acta, Vol 1023, pp. 124â132Â http://dx.doi.org/10.1016/0005-2736(90)90017-I
- Li, D. Duan, L. Freimuth, P. OâMalley and Jr, B.W. (1999) âVariability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancerâ. Clinical Cancer Research, Vol 5, pp. 4175â4181
- Lu¨bbe, A.S. (1996) âClinical experiences with magnetic drug targeting: a phase I study with 4-epidoxorubicin in 14 patients with advanced solid tumors.â Cancer Research;
- Vol. 56, pp. 4686â4693
- Lu¨bbe, A.S. and Bergemann, C. (1998) âMagnetically controlled drug targetingâ The Cancer J, Vol 1, pp. 104â105
- Luo, D. Saltzman, W.M. (2000) âEnhancement of transfection by physical concentration of DNA at the cell surfaceâ. Nature Biotechnology, Vol 18, pp. 893â895
- http://dx.doi.org/10.1038/78523
- Ma, Y. Zhang, Z. Wang, X. Xia, W and Gu, H. (2011) âInsights into the mechanism of magnetofection using MNPs-PEI/pDNA/free PEI magnetofectinsâ. Intnl J Pharmaceutics. Vol 31, 419,
- pp. 247-54Â http://dx.doi.org/10.1016/j.ijpharm.2011.07.017
- Mair, L. (2009) âSize-Uniform 200 nm Particles: Fabrication and Application to Magnetofectionâ. J Biomed Nanotechnology, Vol 5, 10, pp. 182â191
- http://dx.doi.org/10.1166/jbn.2009.1024
- Mendenhall, G.D. Geng, Y. and Hwang, J. (1996) âOptimization of long-term stability of magnetic fluids from magnetite and synthetic polyelectrolytesâ. J Colloid Interface
- Sciences, Vol 184, pp. 519â526Â http://dx.doi.org/10.1006/jcis.1996.0647
- Meyer, K.B. (1995) âIntratracheal gene delivery to the mouse airway: characterization of plasmid DNA expression and pharmacokineticsâ. Gene Therapy, Vol 2, pp. 450â460
- Mykhaylyk, O. Zelphati, O. Rosenecker, J. and Plank, C. (2008) âsiRNA delivery by magnetofectionâ Current Opinion of Molecular Therapy, Vol 10, 5, pp. 493-505
- Pickles, R.J. (2000) âRetargeting the coxsackievirus and adenovirus receptor to the apical surface of polarized epithelial cells reveals the glycocalyx as a barrier to
- adenovirus-mediated gene transferâ. J Virology, Vol 74, pp. 6050â6057. http://dx.doi.org/10.1128/JVI.74.13.6050-6057.2000
- Plank, C. (1994) âThe influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systemsâ. J Biological Chem, Vol 269, pp. 12918â
- Plank, C. Anton, M. Rudolph, C. Rosenecker, J. and KrĂśtz, F. (2003) âEnhancing and targeting nucleic acid delivery by magnetic forceâ. Expert opinion on biological therapy,
- Vol 3, 5, pp.745â758. http://dx.doi.org/10.1517/14712598.3.5.745
- Plank, C. Schillinger, U. and Scherer, F. (2003) âThe magnetofection method: using magnetic force to enhance gene deliveryâ. J Biol Chem, Vol 384, 5, pp. 737â747
- Plank, C. Tang, M. Wolfe, A. and Szoka, F.C. (1999) âBranched cationic peptides for gene delivery. Role of type and number of cationic residues in formation and in vitro
- activity of DNA polyplexesâ. Human Gene Therapy, Vol 10, pp. 319â333Â http://dx.doi.org/10.1089/10430349950019101
- Plank, C. Zelphati, O and Mykhaylyk, O. (2011) âMagnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospectsâ. Advanced Drug Delivery Reviews. Vol 63, 14, pp. 1300-1331Â http://dx.doi.org/10.1016/j.addr.2011.08.002
- Povey, A.C. Bartsch, H. Nixon, J.R. and OâNeill, I.K. (1986) âTrapping of chemical carcinogens with magnetic polyethyleneimine microcapsules: I. Microcapsule preparation
- and in vitro reactivity of encapsulated nucleophilesâ. J Pharm Sci, Vol 75, pp. 831â837. http://dx.doi.org/10.1002/jps.2600750902
- Scherer, F. Anton, M. and Schillinger, U. (2002). âMagnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivoâ. Gene Therapy, Vol 9, 2, pp. 102â109. http://dx.doi.org/10.1038/sj.gt.3301624
- Schillinger, U. Brill, T. Rudolph, C. Huth, S. Gersting, S. and KrĂśtz, F. (2005) âAdvances in magnetofection – magnetically guided nucleic acid deliveryâ J Magnetism and Magnetic Material. Vol 293, pp. 501â508Â http://dx.doi.org/10.1016/j.jmmm.2005.01.032
- Shayakhmetov, D.M. Papayannopoulou, T. Stamatoyannopoulos, G. and Lieber, A. (2000) âEfficient gene transfer into human CD34 (+) cells by a retargeted adenovirus vectorâ. J Virology, Vol 74, pp. 2567â2583Â http://dx.doi.org/10.1128/JVI.74.6.2567-2583.2000
- Sukoyan, M. A. Khrapov, E. A. Voronina, E. N. Boyarskikh, U. A. Gubanov, A. I. Itin, V. I. Magaeva, A. A. Nayden, E. P. Terekhova, O. G and Filipenko, M. L. (2013) âMagnetofection of Human Somatic Cells with Magnetite and Cobalt Ferrospinel Nanoparticlesâ. Bulletin of Exp Biol and Med. Vol 154, 5, pp. 673-676Â http://dx.doi.org/10.1007/s10517-013-2027-2
- Tomko, R.P. Xu, R. and Philipson, L. (1997) âHCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackievirusesâ. Proceedings of the National Academy of Sciences of the United State of America, Vol 94, pp. 3352â3354. http://dx.doi.org/10.1073/pnas.94.7.3352
- Widder, K.J. (1983) âSelective targeting of magnetic albumin microspheres to the Yoshida sarcoma: ultrastructural evaluation of microsphere dispositionâ. European J Cancer Clinical Oncology, Vol 19, pp.141â147Â http://dx.doi.org/10.1016/0277-5379(83)90409-1
- Wu, G.Y. and Wu, C.H. (1987) âReceptor-mediated in vitro gene transformation by a soluble DNA carrier systemâ. The J Biol Chem, Vol 262, pp.4429â4432
- http://www.bocascientific.com/transfectionmagnetofection-c-141.html>
- http://www.chemicell.com/products/Magnetofection/Magnetofection_separation.html>
- http://www.ozbiosciences.com/magnetofection.html>
How to Cite
Sandeep Arora, Girish Gupta, Sukhbir Singh, Neelam Singh. Advances in Magnetofection & â Magnetically Guided Nucleic Acid Delievery:a Review.
J. Pharm. Technol. Res. Manag.. 2013, 01, 19-29